Trial intelligence / Profile preview

CARDIOPLEGIA Trial comparing Custodiol, del Nido, and modified del Nido for myocardial protection

RBR-7g5s66Phase 4Recruiting

Sponsor
Hospital Nossa Senhora da Conceição
Start
Jul 2020
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of HTK Custodiol and del Nido cardioplegia in coronary arteriosclerosis and Cardiac valve disease (VHD) (3 arms), sponsored by Hospital Nossa Senhora da Conceição. Started Jul 2020; status: recruiting.

02

Drugs

HTK Custodioldel Nido cardioplegia
03

Conditions

coronary arteriosclerosisCardiac valve disease (VHD)

Beyond the preview

Go deeper on RBR-7g5s66.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-7g5s66.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call